Koellner Laurette T. - 31 Jan 2025 Form 4 Insider Report for CELESTICA INC (CLS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Feb 2025, 17:08:35 UTC
Prior SEC filing
02 Jan 2025
Next SEC filing
24 Feb 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Tracy Connelly McGilley, attorney-in-fact

Key filing fact

Koellner Laurette T. filed Form 4 for CELESTICA INC (CLS) on 03 Feb 2025.

Key facts

  • This page summarizes Koellner Laurette T.'s Form 4 filing for CELESTICA INC (CLS).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 03 Feb 2025, 17:08.

Change

  • Previous filing in this sequence was filed on 02 Jan 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLS transaction Derivative

Deferred Share Units

Award

Transaction value
$0
Shares
+149
Change %
+0.05%
Price
$0.000000
Shares after
290,635
Date
31 Jan 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
149
Exercise price
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Koellner Laurette T. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

Each deferred share unit represents a contingent right to receive one common share or an equivalent value in cash at the Issuer's discretion when the holder ceases to be (a) a director of the Issuer or (b) an employee of the Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .